Cut to now, when both Wegovy and Zepbound have been removed from the shortage list
Alternatives might include switching to a different GLP-1 medication (some patients tolerate one better than another despite similar mechanisms), reducing the maintenance dose to a level that produces fewer GI effects while still providing benefit, or transitioning to tirzepatide or another agent in the class
Clinical studies indicate that metformin may help reduce visceral fat, particularly in the liver and muscle tissue
Third , the combination lacks robust safety data from controlled trials, meaning potential synergistic effects or unexpected interactions remain inadequately characterized
Hyperplasia, bile ductmultifocal, usually widespread
When appetite is low, protein shakes and Greek yogurt provide easy options that most users tolerate well even during peak side effect periods